SCHEMBL10240528

SCHEMBL10240528

O=S(=O)(Nc1ccc2c(c1)CNCC2)c1csc2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 7/20 0.56
ADRA2A P08913 2/20 0.50
HTR1A P08908 1/20 0.50
PNMT P11086 5/20 0.48
HTR2C P28335 4/20 0.47
DRD2 P14416 2/20 0.47
HTR2A P28223 2/20 0.47
DRD3 P35462 2/20 0.47
HTR2B P41595 1/20 0.44
PDPK1 O15530 1/20 0.41
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
KMT2A Q03164 1/20 0.40
MLNR O43193 1/20 0.40
ADRA2B P18089 1/20 0.40
ADRA2C P18825 1/20 0.40
GHSR Q92847 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9957936 0.99 HTR6 (0.55) HTR6ADRA2AHTR1APNMTHTR2C
SCHEMBL13757765 0.96 HTR6 (0.52) HTR6ADRA2AHTR1APNMTHTR2C
Hydrochloric Acid SCHEMBL9958145 0.94 HTR6 (0.51) HTR6ADRA2AHTR1APNMTHTR2C
SCHEMBL10238657 0.81 HTR6 (0.55) HTR6PNMTHTR2CDRD2HTR2A
Hydrochloric Acid SCHEMBL9960412 0.80 HTR6 (0.54) HTR6PNMTHTR2CDRD2HTR2A
SCHEMBL10240571 0.79 HTR6 (0.53) HTR6PNMTHTR2CDRD2HTR2A
SCHEMBL10240580 0.79 PNMT (0.55) HTR6ADRA2APNMTHTR2CDRD2
SCHEMBL10239980 0.79 HTR6 (0.53) HTR6ADRA2APNMTHTR2CDRD2
Hydrochloric Acid SCHEMBL9959737 0.78 HTR6 (0.52) HTR6PNMTHTR2CDRD2HTR2A
SCHEMBL10240500 0.78 HTR6 (0.48) HTR6ADRA2AHTR1APNMTHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007729-B1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS, THEIR PREPARATION AND USE IN MEDICAMENTS ESTEVE LABOR DR (ES) 2012-06-27 EP disclosed
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2009-08-20 US disclosed
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS LABORATORIOS DEL DR. ESTEVE S.A. (ES) 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209528-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUND, THEIR PREPARATION AND USE IN MEDICAMENTS HTR6, HTR5A, HTR7 HTR6 1/4885ADRA2A 82/4885HTR1A 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.